{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:22:24Z","timestamp":1785252144806,"version":"3.55.0"},"reference-count":50,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Slovenian Research Agency","award":["P3-067"],"award-info":[{"award-number":["P3-067"]}]},{"name":"Slovenian Research Agency","award":["P3-0326"],"award-info":[{"award-number":["P3-0326"]}]},{"name":"Slovenian Research Agency","award":["20180033"],"award-info":[{"award-number":["20180033"]}]},{"name":"Slovenian Research Agency","award":["20210037"],"award-info":[{"award-number":["20210037"]}]},{"name":"University Medical Centre Ljubljana","award":["P3-067"],"award-info":[{"award-number":["P3-067"]}]},{"name":"University Medical Centre Ljubljana","award":["P3-0326"],"award-info":[{"award-number":["P3-0326"]}]},{"name":"University Medical Centre Ljubljana","award":["20180033"],"award-info":[{"award-number":["20180033"]}]},{"name":"University Medical Centre Ljubljana","award":["20210037"],"award-info":[{"award-number":["20210037"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian cancer (OC), particularly high-grade serous carcinoma (HGSC), is a leading cause of gynecological cancer mortality due to late diagnosis and chemoresistance. While studies on OC cell lines have shown that overexpression of the ATP7A membrane transporter correlates with resistance to platinum-based drugs (PtBMs) and cross-resistance to copper (Cu), clinical evidence is lacking. The functionality of ceruloplasmin (CP), the main Cu-transporting protein in the blood, is dependent on, among other things, ATP7A activity. This study investigated ATP7A expression and CP levels as potential biomarkers for predicting responses to PtBMs. We included 28 HGSC patients who underwent neoadjuvant chemotherapy (NACT). ATP7A expression in ovarian and peritoneal tissues before NACT and in peritoneal and omental tissues after NACT was analyzed via qPCR, and CP levels in ascites and plasma were measured via ELISA before and after NACT. In total, 54% of patients exhibited ATP7A expression in pretreatment tissue (ovary and\/or peritoneum), while 43% of patients exhibited ATP7A expression in tissue after treatment (peritoneum and\/or omentum). A significant association was found between higher ATP7A expression in the peritoneum before NACT and an unfavorable CA-125 elimination rate constant k (KELIM) score. Patients with omental ATP7A expression had significantly higher plasma mean CP levels before NACT. Plasma CP levels decreased significantly after NACT, and higher CP levels after NACT were associated with a shorter platinum-free interval (PFI). These findings suggest that the ATP7A transporter and CP have the potential to serve as predictive markers of chemoresistance, but further research is needed to validate their clinical utility.<\/jats:p>","DOI":"10.3390\/ijms251810195","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:15:07Z","timestamp":1727082907000},"page":"10195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of ATP7A Expression and Ceruloplasmin Levels as Biomarkers in Patients Undergoing Neoadjuvant Chemotherapy for Advanced High-Grade Serous Ovarian Carcinoma"],"prefix":"10.3390","volume":"25","author":[{"given":"David","family":"Lukanovi\u0107","sequence":"first","affiliation":[{"name":"Department of Gynecology, Division of Gynecology and Obstetrics, University Medical Centre Ljubljana, Zalo\u0161ka 2, SI-1000 Ljubljana, Slovenia"},{"name":"Department of Gynecology and Obstetrics, Faculty of Medicine, University of Ljubljana, \u0160lajmerjeva 3, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Polaj\u017eer","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miha","family":"Matja\u0161i\u010d","sequence":"additional","affiliation":[{"name":"Department of Education Studies, Faculty of Education, University of Ljubljana, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-7699","authenticated-orcid":false,"given":"Borut","family":"Kobal","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Division of Gynecology and Obstetrics, University Medical Centre Ljubljana, Zalo\u0161ka 2, SI-1000 Ljubljana, Slovenia"},{"name":"Department of Gynecology and Obstetrics, Faculty of Medicine, University of Ljubljana, \u0160lajmerjeva 3, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"\u010cerne","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana, Korytkova 2, SI-1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ejca.2015.07.022","article-title":"Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: Results of the EUROCARE-5 study","volume":"51","author":"Sant","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lukanovi\u0107, D., Herzog, M., Kobal, B., and \u010cerne, K. (2020). The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. Biomed. Pharmacother., 129.","DOI":"10.1016\/j.biopha.2020.110401"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/reprodmed3020011","article-title":"Ovarian Cancer: Treatment and Resistance to Pharmacotherapy","volume":"3","author":"Kobal","year":"2022","journal-title":"Reprod. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube","volume":"8","author":"Papp","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: Results of EUROCARE-5\u2014A population-based study","volume":"15","author":"Sant","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_7","unstructured":"National Comprehensive Cancer Network (2024, August 10). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Ovarian cancer (Version 1.2024). Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00404-016-4035-8","article-title":"The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications","volume":"293","author":"Fotopoulou","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lisio, M.A., Fu, L., Goyeneche, A., Gao, Z.H., and Telleria, C. (2019). High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040952"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/annonc\/mdz062","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"30","author":"Colombo","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Herzog, M., Verdenik, I., Kobal, B., and \u010cerne, K. (2024). Higher EpCAM-Positive Extracellular Vesicle Concentration in Ascites Is Associated with Shorter Progression-Free Survival of Patients with Advanced High-Grade Serous Carcinoma. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126780"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cornelison, R., Llaneza, D.C., and Landen, C.N. (2017). Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102171"},{"key":"ref_13","unstructured":"Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2002). Molecular Biology of the Cell, Garland Science."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Diaz-Padilla, I. (2013). Molecular mechanisms of platinum resistance in ovarian cancer. Ovarian Cancer\u2014A Clinical and Translational Update, InTech.","DOI":"10.5772\/56234"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lai, Y.H., Kuo, C., Kuo, M.T., and Chen, H.H.W. (2018). Modulating chemosensitivity of tumors to platinum-based antitumor drugs by transcriptional regulation of copper homeostasis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051486"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/17425255.2017.1332179","article-title":"The role of membrane transporters in ovarian cancer chemoresistance and prognosis","volume":"13","author":"Cerovska","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_17","first-page":"5853","article-title":"Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients","volume":"9","author":"Samimi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1158\/1078-0432.CCR-03-0454","article-title":"Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy","volume":"10","author":"Nakayama","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3892\/or.2016.4599","article-title":"Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma","volume":"35","author":"Elsnerova","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/0008-5472.CAN-03-2551","article-title":"Selective activation of ceruloplasmin promoter in ovarian tumors: Potential use for gene therapy","volume":"64","author":"Lee","year":"2004","journal-title":"Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","article-title":"The molecular mechanisms of copper metabolism and its roles in human diseases","volume":"472","author":"Chen","year":"2020","journal-title":"Pflugers Arch."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, H., Li, Y., Liu, J., Zheng, M., Feng, Y., Hu, K., Huang, Y., and Huang, Q. (2012). Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051256"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hojnik, M., \u0160uster, N.K., Smrkolj, \u0160., Sisinger, D., Grazio, S.F., Verdenik, I., and Ri\u017ener, T.L. (2022). AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers, 14.","DOI":"10.3390\/cancers14030809"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The Different Mechanisms of Cancer Drug Resistance: A Brief Review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41416-019-0648-6","article-title":"Principles and mechanisms of non-genetic resistance in cancer","volume":"122","author":"Bell","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: Past, present and future","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_27","first-page":"6559","article-title":"Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper","volume":"62","author":"Katano","year":"2002","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kalayda, G.V., Wagner, C.H., Buss, I., Reedijk, J., and Jaehde, U. (2008). Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer, 8.","DOI":"10.1186\/1471-2407-8-175"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1158\/1078-0432.CCR-04-0137","article-title":"Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells","volume":"10","author":"Samimi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jimd.12590","article-title":"ATP7A-related copper transport disorders: A systematic review and definition of the clinical subtypes","volume":"46","author":"Beyens","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ijnp\/pyaa038","article-title":"Correlations Among mRNA Expression Levels of ATP7A, Serum Ceruloplasmin Levels, and Neuronal Metabolism in Unmedicated Major Depressive Disorder","volume":"23","author":"Liu","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2478\/raon-2018-0030","article-title":"Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: Comparison of survivals","volume":"52","author":"Kobal","year":"2018","journal-title":"Radiol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1515\/raon-2016-0034","article-title":"The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer","volume":"50","author":"Merlo","year":"2016","journal-title":"Radiol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-20-0054","article-title":"CA-125 ELIMination rate constant K (KELIM) is a marker of Chemosensitivity in patients with ovarian Cancer: Results from the phase II CHIVA trial","volume":"26","author":"You","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102294","DOI":"10.1016\/j.ctrv.2021.102294","article-title":"The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas","volume":"100","author":"You","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.20517\/cdr.2022.01","article-title":"Ovarian cancer recurrence: Is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? A clinical perspective","volume":"5","author":"Rose","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.18632\/aging.203427","article-title":"Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lane, D., Matte, I., Garde-Granger, P., Laplante, C., Carignan, A., Rancourt, C., and Pich\u00e9, A. (2015). Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1511-7"},{"key":"ref_39","unstructured":"Feldman, A.M., Groszmann, R.J., and Sass, D.A. (2017). Pathophysiology of ascites. Ascites: Pathophysiology, Diagnosis, and Management, Elsevier."},{"key":"ref_40","first-page":"108","article-title":"Copper and ceruloplasmin status in serum of prostate and colon cancer patients","volume":"47","author":"Nayak","year":"2003","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jcar.jcar_10_21","article-title":"Serum ceruloplasmin as cancer marker in oral pre-cancers and cancers","volume":"20","author":"Patil","year":"2021","journal-title":"J. Carcinog."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/labinvest.3700044","article-title":"cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model","volume":"84","author":"Kluger","year":"2004","journal-title":"Lab. Investig."},{"key":"ref_43","first-page":"103","article-title":"Evaluation of ceruloplasmin concentration in prognosis of human cancer","volume":"40","author":"Chakravarty","year":"1986","journal-title":"Acta Med. Okayama"},{"key":"ref_44","first-page":"46","article-title":"Serum protein fractions in patients with laryngeal cancer undergoing radiation therapy: Possibility as a prognostic factor","volume":"90","author":"Onizuka","year":"1999","journal-title":"Fukuoka Igaku Zasshi"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1023\/A:1008407014084","article-title":"Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients","volume":"9","author":"Weijl","year":"1998","journal-title":"Ann. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"29023","DOI":"10.1038\/srep29023","article-title":"The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data","volume":"6","author":"Korenkova","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Blagden, S.P. (2015). Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00149"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","article-title":"Metastasis as an evolutionary process","volume":"352","author":"Turajlic","year":"2016","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Roberts, C.M., Cardenas, C., and Tedja, R. (2019). The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis. Cancers, 11.","DOI":"10.3390\/cancers11081083"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1038\/onc.2011.134","article-title":"P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium\/calpain-dependent mechanism","volume":"30","author":"Fraser","year":"2011","journal-title":"Oncogene"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:02:45Z","timestamp":1760112165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":50,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms251810195"],"URL":"https:\/\/doi.org\/10.3390\/ijms251810195","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}